Related Experiment Video
Updated: May 28, 2025
Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
Currents status of radiotracers for breast cancer imaging in PET
Chloé Jean1, Stéphane Roux2, Abdelilah Aziz3
1Université de Reims Champagne Ardenne, UMR CNRS 7369 MEDyC, Reims, France; Université de Reims Champagne Ardenne, CRESTIC, Reims, France.
Abstract:
Radiolabeled molecules have become valuable tools in the diagnosis, monitoring, and treatment of cancer, particularly breast cancer. Through the use of radiotracers, clinicians can target specific tumor cells, assess microenvironments, and identify metastases. These radiopharmaceuticals, based on radionuclides, enable both imaging and therapeutic applications, leading to personalized cancer treatment. Techniques such as PET, SPECT, and the use of nanoparticles for theranostics are at the forefront of innovation, offering improved precision in both diagnosis and therapy. This review explores the various ways in which radiotracers are leveraged in modern oncology, with a focus on breast cancer, and highlights recent advancements in targeted radionuclide therapy and nanoparticle-based applications.
Insights
Radiolabeled molecules and radiotracers are revolutionizing cancer care, especially for breast cancer. These tools enable precise diagnosis, monitoring, and personalized treatment through advanced imaging and targeted radionuclide therapy.
Area of Science:
- Nuclear medicine
- Oncology
- Radiopharmaceutical science
Background:
- Radiolabeled molecules are essential in modern oncology.
- They are particularly valuable for breast cancer diagnosis, monitoring, and treatment.
- Radiotracers allow for targeted tumor cell identification and microenvironment assessment.
Purpose of the Study:
- To review the applications of radiotracers in oncology, focusing on breast cancer.
- To highlight advancements in targeted radionuclide therapy.
- To explore nanoparticle-based theranostic applications.
Main Methods:
- Review of current literature on radiopharmaceuticals in cancer.
- Discussion of imaging techniques like PET and SPECT.
- Analysis of nanoparticle applications in theranostics.
Main Results:
- Radiotracers enable precise targeting of tumor cells and metastases.
- Radiopharmaceuticals offer both diagnostic and therapeutic benefits.
- Innovations include advanced imaging and targeted radionuclide therapies.
Conclusions:
- Radiolabeled molecules are pivotal for personalized cancer treatment.
- Advancements in radiotracer technology are improving precision in oncology.
- Nanoparticle-based theranostics represent a significant frontier in cancer care.
More Related Videos
Related Concept Videos
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...